Search
for
Sort by
Research 91–120 of 227
- LB1034 Meta-analysis of scalp transcriptome defines alopecia areata subtypes and molecular response to four (4) treatments with jak inhibiting properties
- Pharmacologic inhibition of JAK-STAT signaling promotes hair growth
- Targeting the Janus Kinase Family in Autoimmune Skin Diseases
- Evaluating the Therapeutic Potential of Ritlecitinib for the Treatment of Alopecia Areata
- JAK inhibition in the treatment of alopecia areata – a promising new dawn?
- Off-Label Uses of Abrocitinib: Review of Emerging Therapeutic Applications beyond Atopic Dermatitis
- From mechanisms to therapies: current advances breakthroughs in alopecia areata immunopathology
- 496 Understanding the mechanism of action of secukinumab using lesional hidradenitis suppurativa skin organ culture
- The JAK/STAT signaling pathway: from bench to clinic
- Alopecia Areata: An Updated Review for 2023
- Tyrosine Kinases in Autoimmune and Inflammatory Skin Diseases
- Vitiligo: An Autoimmune Skin Disease and its Immunomodulatory Therapeutic Intervention
- Alopecia Areata: Current Treatments and New Directions
- Selective inhibition of JAK3 signaling is sufficient to reverse alopecia areata
- Profile of tofacitinib citrate and its potential in the treatment of moderate-to-severe chronic plaque psoriasis
- SOCS1 and SOCS3 as key checkpoint molecules in the immune responses associated to skin inflammation and malignant transformation
- Palmoplantar pustulosis–like eruption following tofacitinib therapy for juvenile idiopathic arthritis
- Immunopathology and Immunotherapy of Inflammatory Skin Diseases
- Application of Baricitinib in Dermatology
- Alopecia areata – Current understanding and management
- Mechanisms of autophagy and their implications in dermatological disorders
- Immune therapies for alopecia areata: evidence and new perspectives
- Inhibition of T-cell activity in alopecia areata: recent developments and new directions
- Efficacy of Upadacitinib in Treating Alopecia Areata, Atopic Dermatitis, and Th1 Comorbidities in Pediatric Patients: A Comprehensive Case Series and Literature Review
- JAK inhibition decreases the autoimmune burden in Down syndrome
- Ruxolitinib Rescues Multiorgan Clinical Autoimmunity in Patients with APS-1
- Alopecia areata – Aktuelles Verständnis und Management
- Tofacitinib Treatment in Patients With Active COVID-19 Infection
- Dermal T cell immunity and key regulatory signaling pathways: Implications in immune-mediated alopecia and hair regeneration
- Clinical and Genetic Aspects of Alopecia Areata: A Cutting Edge Review